These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Development of a new family of conformationally restricted peptides as potent nucleators of beta-turns. Design, synthesis, structure, and biological evaluation of a beta-lactam peptide analogue of melanostatin. Palomo C; Aizpurua JM; Benito A; Miranda JI; Fratila RM; Matute C; Domercq M; Gago F; Martin-Santamaria S; Linden A J Am Chem Soc; 2003 Dec; 125(52):16243-60. PubMed ID: 14692766 [TBL] [Abstract][Full Text] [Related]
25. Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones. Finke PE; Shah SK; Fletcher DS; Ashe BM; Brause KA; Chandler GO; Dellea PS; Hand KM; Maycock AL; Osinga DG J Med Chem; 1995 Jun; 38(13):2449-62. PubMed ID: 7608910 [TBL] [Abstract][Full Text] [Related]
26. 3-Methylidene-beta-lactams as potential inhibitors of beta-lactamases. Part 1: Synthesis of alpha-substituted derivatives from imines by Reformatzky reaction with chlorotrimethylsilane, silylation and Peterson olefination. Gürtler S; Ruf S; Johner M; Otto HH Pharmazie; 1996 Nov; 51(11):811-5. PubMed ID: 8985976 [TBL] [Abstract][Full Text] [Related]
29. Amino acids and peptides. XXX. Synthesis of eglin c (41-49) and eglin c (60-63) and examination of their inhibitory activity towards human leukocyte elastase, cathepsin G, porcine pancreatic elastase and alpha-chymotrypsin. Tsuboi S; Takeda M; Okada Y; Nagamatsu Y; Yamamoto J Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):184-6. PubMed ID: 2049802 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological investigation of the β-thiolactone and β-lactam analogs of tetrahydrolipstatin. Aubry S; Aubert G; Cresteil T; Crich D Org Biomol Chem; 2012 Apr; 10(13):2629-32. PubMed ID: 22354549 [TBL] [Abstract][Full Text] [Related]
31. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins. Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634 [TBL] [Abstract][Full Text] [Related]
32. Mechanistic insights into the inhibition of serine proteases by monocyclic lactams. Wilmouth RC; Kassamally S; Westwood NJ; Sheppard RJ; Claridge TD; Aplin RT; Wright PA; Pritchard GJ; Schofield CJ Biochemistry; 1999 Jun; 38(25):7989-98. PubMed ID: 10387042 [TBL] [Abstract][Full Text] [Related]
33. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome. Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212 [TBL] [Abstract][Full Text] [Related]
34. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives. Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171 [TBL] [Abstract][Full Text] [Related]
35. Isothiourea-catalyzed asymmetric synthesis of β-lactams and β-amino esters from arylacetic acid derivatives and N-sulfonylaldimines. Smith SR; Douglas J; Prevet H; Shapland P; Slawin AM; Smith AD J Org Chem; 2014 Feb; 79(4):1626-39. PubMed ID: 24432704 [TBL] [Abstract][Full Text] [Related]
36. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor. Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591 [No Abstract] [Full Text] [Related]
37. Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones. Skiles JW; Fuchs V; Miao C; Sorcek R; Grozinger KG; Mauldin SC; Vitous J; Mui PW; Jacober S; Chow G J Med Chem; 1992 Feb; 35(4):641-62. PubMed ID: 1542092 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect by new monocyclic 4-alkyliden-beta-lactam compounds on human platelet activation. Pavanetto M; Zarpellon A; Giacomini D; Galletti P; Quintavalla A; Cainelli G; Folda A; Scutari G; Deana R Platelets; 2007 Aug; 18(5):357-64. PubMed ID: 17654305 [TBL] [Abstract][Full Text] [Related]
39. Linear and Cyclic Depsipeptidomimetics with β-Lactam Cores: A Class of New α Zabala-Uncilla N; Miranda JI; Laso A; Fernández X; Ganboa JI; Palomo C Chembiochem; 2017 Apr; 18(7):654-665. PubMed ID: 28140512 [TBL] [Abstract][Full Text] [Related]
40. Design of beta-lactams with mechanism based nonantibacterial activities. Veinberg G; Vorona M; Shestakova I; Kanepe I; Lukevics E Curr Med Chem; 2003 Sep; 10(17):1741-57. PubMed ID: 12871119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]